13F Holdings
中文EN

Euclidean Capital LLC

NEW YORK NY · SEC CIK 0001825034

2026Q22026Q1 9 earlier quarters 🔒
$439.84M2026Q2 reported value
11Positions
100.0%Top 10 weight · largest 61.8%
0 / 0New / sold out
Reported value over time$439.84M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

VEU 61.8%
VTV 25.8%
INDA 4.2%
ORIC 2.4%
TMS 2.1%
FHTX 1.7%
PMV PHARMACEUT 0.8%
ALEC 0.6%
SRZN 0.5%
TENAYA THERAPE 0.2%

2026Q2 top buys estimated at quarter-end value

No buys this quarter

2026Q2 top sells estimated at quarter-end value

No sells this quarter

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
VEU VANGUARD INTL EQUITY INDEX F $271.64M61.76%3,243,484 00.0% — Unchanged
VTV VANGUARD INDEX FDS $113.32M25.76%520,000 00.0% — Unchanged
INDA ISHARES TR $18.25M4.15%369,600 00.0% — Unchanged
ORIC ORIC PHARMACEUTICALS INC $10.72M2.44%989,410 00.0% — Unchanged
TMS TEAMSHARES INC $9.04M2.06%1,099,974 1,099,974— — First reported
FHTX FOGHORN THERAPEUTICS INC $7.68M1.75%1,573,761 00.0% — Unchanged
— PMV PHARMACEUTICALS INC $3.52M0.80%2,627,643 00.0% — Unchanged
ALEC ALECTOR INC $2.63M0.60%1,307,858 00.0% — Unchanged
SRZN SURROZEN INC $2.28M0.52%87,696 00.0% — Unchanged
— TENAYA THERAPEUTICS INC $750,7080.17%1,015,705 00.0% — Unchanged
— SURROZEN INC $2,8190.00%170,833 00.0% — Unchanged